Aspirin: New cardiovascular uses for an old drug

American Journal of Medicine

Volumn 110, Issue 1 SUPPL. 1, 2001, Pages S62-S65

  Patrono, Carlo ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; THROMBOXANE SYNTHASE INHIBITOR;

ACUTE HEART INFARCTION; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG USE; ENZYME INHIBITION; GASTROINTESTINAL TOXICITY; HUMAN; PRIORITY JOURNAL; REVIEW; THROMBOSIS;

EID: 0035825137     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(00)00645-8     Document Type: Review

References (17)

1. Aspirin as an antiplatelet drug
2. Cyclooxygenase-2 inhibitors in tumorigenesis (part I)
3. Cyclooxygenase-2 inhibitors in tumorigenesis (part II)
4. Role of platelet activation in dementia
5. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina
6. The gastrointestinal toxicity of aspirin: An overview of randomized controlled trials
7. Extent, mode, and dose dependence of anticancer effects
8. Platelet-active drugs. The relationship among dose effectiveness, and side effects
9. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
10. Final report on the aspirin component of the ongoing Physicians' Health Study
11. Thrombosis prevention trial: Randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk
12. Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
13. Aspirin in ischemic cerebrovascular disease: How strong is the case for a different dosing regimen?
14. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: A randomised controlled trial
15. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
16. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs
17. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial